Aengus Mac Sweeney

10PUBLICATIONS
28CO-AUTHORS
Proteins and peptidesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designGlycoconjugatesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 03, 2025
The CASP 16 Experimental Protein-Ligand Datasets.

Andreas Tosstorff, Markus G Rudolph, Jörg Benz

|Sep 26, 2025
Cellular Potency Optimization of Novel Heme-Binding Imidazo[5,1-<i>b</i>]thiazoles, Imidazo[1,5-<i>a</i>]pyridines and Pyrazines as Potent IDO1 Inhibitors Devoid of Cytochrome P450 Inhibition.

Sylvaine Cren, Carina Lotz-Jenne, Thierry Kimmerlin

|Apr 05, 2025
Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations.

Julien Hazemann, Thierry Kimmerlin, Aengus Mac Sweeney

|Mar 12, 2025
Discovery of Galactopyranose-1-carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin-3 Inhibitors.

Cornelia Zumbrunn, Luboš Remen, Christoph P Sager

|Jun 24, 2024
Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for <i>de novo</i> drug design and computational chemistry approaches.

Julien Hazemann, Thierry Kimmerlin, Roland Lange

|Feb 20, 2020
Discovery of 4-((2<i>S</i>,4<i>S</i>)-4-Ethoxy-1-((5-methoxy-7-methyl-1<i>H</i>-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.

Nello Mainolfi, Takeru Ehara, Rajeshri G Karki

Pageof 2

Frequent Collaborators

3 joint publications

Julien Hazemann

2 joint publications

Paul Czodrowski

1 joint publications

Joscha Breibeck

1 joint publications

Jörg Eder